Identification of SIN pathway targets reveals mechanisms of crosstalk between NDR kinase pathways
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Gupta, SnehaMana-Capelli, Sebastian
McLean, Janel R.
Chen, Chun-Ti
Ray, Samriddha
Gould, Kathleen L.
McCollum, Dannel
UMass Chan Affiliations
Program in Cell DynamicsDepartment of Microbiology and Physiological Systems
Document Type
Journal ArticlePublication Date
2013-02-18
Metadata
Show full item recordAbstract
The septum initiation network (SIN) regulates multiple functions during late mitosis to ensure successful completion of cytokinesis in Schizosaccharomyces pombe. One mechanism by which the SIN promotes cytokinesis is by inhibiting a competing polarity pathway called the MOR, which is required for initiation of polarized growth following completion of cytokinesis. Mutual antagonism between the two NDR kinase pathways, SIN and MOR, is required to coordinate cytoskeletal rearrangements during the mitosis-interphase transition. To determine how the SIN regulates the MOR pathway, we developed a proteomics approach that allowed us to identify multiple substrates of the SIN effector kinase Sid2, including the MOR pathway components Nak1 kinase and an associated protein, Sog2. We show that Sid2 phosphorylation of Nak1 causes removal of Nak1 from the spindle pole bodies, which may both relieve Nak1 inhibition of the SIN and block MOR signaling by preventing interaction of Nak1 with the scaffold protein Mor2. Because the SIN and MOR are conserved in mammalian cells (Hippo and Ndr1/2 pathways, respectively), this work may provide important insight into how the activities of these essential pathways are coordinated.Source
Curr Biol. 2013 Feb 18;23(4):333-8. doi: 10.1016/j.cub.2013.01.014. Link to article on publisher's siteDOI
10.1016/j.cub.2013.01.014Permanent Link to this Item
http://hdl.handle.net/20.500.14038/29612PubMed ID
23394829Notes
First author Sneha Gupta is a doctoral student in the Interdisciplinary Graduate Program in the Graduate School of Biomedical Sciences (GSBS) at UMass Medical School.
Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.cub.2013.01.014